Even though artificial intelligence (AI) has been in the spotlight for several years, not every strong opportunity is getting equal attention. While stalwarts like Nvidia continue to command the spotlight, a quieter gro…
Internal Revenue Service CEO Frank Bisignano dismissed allegations that he spied on his fellow executives while working at JPMorgan Chase more than a decade age. "None of it's true," Bisignano told CNBC on Tuesday.
Cotton price action early on Tuesday is 60 to 95 points higher on Tuesday morning. Futures were up 9 to 37 points across most contracts on Monday. Crude oil was up another 65 cents per barrel, with the US dollar index u…
Looking at the chart above, ITA's low point in its 52 week range is $190.16 per share, with $251.49 as the 52 week high point — that compares with a last trade of $231.32. Comparing the most recent share price to the 20…
When they head to the polls in November, Americans will have a rare opportunity to use their voting power to directly shape tax policy. Ballooning government spending and growing tax burdens across the U.S. have led to …
While parts of the U.S. economy are reopening after months of shutdown to curb the coronavirus pandemic, many office workers are entering their fourth month of working from home. Major companies, including Twitter and F…
In this episode of The Morning Filter podcast, co-hosts Dave Sekera and Susan Dziubinski unpack the stock market’s response to the US-Iran ceasefire and discuss how investors should be thinking about their portfolios as…
Elon Musk warned that investors betting against SpaceX have little chance of survival — even as short sellers boosted their wagers against the company to about one-third of its publicly tradable shares ahead of several …
Nvidia became the most valuable company because of insatiable demand for its graphics processing unit, or GPU, the primary chip used for creating and deploying artificial intelligence.
Let me tell you a sad story: In order to comfortably raise a family in an expensive coastal city like San Francisco or New York, you've got to make at least $300,000 a year. You can certainly raise a family earning less…
What happened: 3M (MMM) stock jumped more than 6% in premarket trading on Tuesday after the industrial conglomerate beat Wall Street's earnings expectations and raised its full-year guidance.
The wheat complex was mostly lower on Monday, with winter wheat falling and spring wheat holding up. Chicago SRW contracts were 4 1/4 to 8 3/4 cents in the red at the close. KC HRW futures were down 4 1/4 to 8 1/2 cents…
SpaceX's stock gained 7% on Tuesday, attempting to snap a seven-day losing streak after setting its maiden earnings report, which coincides with a major share lock-up expiration.
D.R. Horton (DHI) came out with quarterly earnings of $3.2 per share, beating the Zacks Consensus Estimate of $2.99 per share. This compares to earnings of $3.36 per share a year ago. These figures are adjusted for non-…
Perhaps those worried about the sell-offs in momentum memory chip stocks such as Micron (MU) and Sandisk (SNDK) should read the second quarter earnings release from auto giant General Motors (GM).
Synchrony (SYF) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.08 per share. This compares to earnings of $2.5 per share a year ago. These figures are adjusted for non-re…
Time to buy the dip in momentum stocks after a punishing July drawdown? Here’s what history tells us. Investors who can stomach a little short-term volatility are often rewarded. Read at source
Hasbro (HAS) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.17 per share. This compares to earnings of $1.3 per share a year ago. These figures are adjusted for non-recur…
Cotton futures were up 9 to 37 points across most contracts on Monday. Crude oil was up another 65 cents per barrel, with the US dollar index up 0.209.
Novo Nordisk on Tuesday filed a lawsuit against Eli Lilly, alleging that its advertising campaigns for its blockbuster obesity and diabetes drugs are designed to mislead consumers about their superior efficacy relative …